Elizabeth A. Hoge, MD; Eric Bui, MD, PhD; Mihriye Mete, PhD; et al.
free access
JAMA Psychiatry. 2023;80(1):13-21. doi:10.1001/jamapsychiatry.2022.3679
This randomized clinical trial evaluates whether mindfulness-based stress reduction is noninferior to escitalopram in the treatment of anxiety disorders.
Vandad Sharifi, MD; Zahra Shahrivar, MD; Hadi Zarafshan, PhD; et al.
open access
JAMA Psychiatry. 2023;80(1):22-30. doi:10.1001/jamapsychiatry.2022.3989
This cluster randomized trial explores the effect of adding a child and youth component to an existing collaborative care program in Iran on child mental health outcomes and receipt of care.
Milja Hartikainen, MD; Heidi Taipale, PhD; Antti Tanskanen, PhD; et al.
open access
has audio
JAMA Psychiatry. 2023;80(1):31-39. doi:10.1001/jamapsychiatry.2022.3788
This cohort study evaluates the association of commonly used pharmacological treatments with hospitalization and mortality outcomes in individuals with amphetamine use disorders.
-
Podcast:
Association of Pharmacological Treatments and Hospitalization and Death in Amphetamine Use Disorders in Sweden
Craig Morgan, PhD; Alex Cohen, PhD; Georgina Miguel Esponda, PhD; et al.
open access
JAMA Psychiatry. 2023;80(1):40-48. doi:10.1001/jamapsychiatry.2022.3781
This cohort study investigates if the clinical and demographic profiles of individuals with, and rates of, untreated psychoses vary across diverse settings in the Global South.
Cale N. Basaraba, MPH; Jennifer M. Scodes, MSc; Renald Dambreville, MSc; et al.
free access
JAMA Psychiatry. 2023;80(1):49-56. doi:10.1001/jamapsychiatry.2022.3571
This cohort study uses longitudinal data for people with first-episode psychosis to develop a prediction tool for the trajectory of education and work over a year of quarterly follow-up assessments.
Tom Alan Ranger, PhD; Ash Kieran Clift, MBBS; Martina Patone, PhD; et al.
open access
has active quiz
JAMA Psychiatry. 2023;80(1):57-65. doi:10.1001/jamapsychiatry.2022.3614
This cohort study investigates the potential association between a previous diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection and other severe acute respiratory infections.
Jacqueline-Marie N. Ferland, PhD; Randall J. Ellis, BS; Graeme Betts, BKin; et al.
free access
JAMA Psychiatry. 2023;80(1):66-76. doi:10.1001/jamapsychiatry.2022.3915
This study leverages a human data set of cannabis users and a rat model to evaluate the long-term outcomes of adolescent 螖9-tetrahydrocannabinol (THC) exposure on adult decision-making and impulse control.